Results 131 to 136 of about 492 (136)

A Descriptive Analysis from VigiAccess on Drug-related Problems Associated with the Glucagon-like Peptide-1 Receptor Agonists

Current Drug Safety
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely accepted for managing Type 2 diabetes mellitus. However, numerous drug-related problems (DRPs) have recently been reported about GLP-1 RAs. Objectives: The present descriptive study aimed to compile and report the DRPs of various GLP-1 RAs.
openaire   +2 more sources

Top bar navigation

Frontiers in Pharmacology
Yu Zhao
exaly   +6 more sources

WHO grants public access to VigiBase via VigiAccess interface

Reactions Weekly, 2015
openaire   +1 more source

Sparsentan-related AE reports in VigiAccess and FAERS

Reactions Weekly
openaire   +1 more source

Analysis of adverse reaction characteristics of four biologics for the treatment of chronic sinusitis with nasal polyps: A descriptive analysis from WHO-VigiAccess

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Fan Ye
exaly  

EPH74 COMPARATIVE POST-MARKETING SAFETY STUDY OF NIRSEVIMAB AND PALIVIZUMAB: A PHARMACOVIGILANCE ANALYSIS USING FAERS AND WHO VIGIACCESS

Value in Health
nipa chowdhury, Mohammad Al-Mamun
openaire   +1 more source